ABD-3001

• Description :

  ABD-3001 is an inhibitor of ALDH1. ABD-3001 can be studied in research on refractory/relapsed acute myeloid leukemia and high-risk myelodysplastic syndrome[1].

• UNSPSC :

  12352211

• Target :

  Aldehyde Dehydrogenase (ALDH)

• Related Pathways :

  Metabolic Enzyme/Protease

• Applications :

  Cancer-programmed cell death

• Field of Research :

  Cancer

• Smiles :

  O=C(SC)C#CC(C)(C)N(C)C

• Molecular Formula :

  C9H15NOS

• Molecular Weight :

  185.29

• References & Citations :

  [1]Lina Benajiba, et al., Odyssey: A First-in-Human Study of the Aldehyde Dehydrogenase (ALDH) Inhibitor Abd-3001 in Patients with Refractory/Relapsed Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS) . Blood, 2024 144 (1) : 6001.

• Shipping Conditions :

  Room temperature

• Scientific Category :

  Reference compound1

• Clinical Information :

  No Development Reported

• CAS Number :

  [350229-29-7]